Annual Meeting 2024 Inno4Vac: innovations to accelerate vaccine development and manufacture
Newsroom
Check on Inno4Vac latest news
Successful Regulatory Exchange on 3D Mucosal Models for Vaccine Development at RIVM
Inno4Vac interim review: advancing scientific and technological progress
Face to face VAXPRED meeting 31st May 2024
Four Key Reports highlighting regulatory and ethical aspects of the Controlled Human Infection Models
New findings on vaccine efficacy prediction: comprehensive antibody repertoire profiling
Regulatory engagement – continuing dialogue between ST4 model developers and EMA QIG
Annual Meeting 2023 Inno4Vac: innovations to accelerate vaccine development and manufacture
Online platform on bio-manufacturing: workshop on integrating in silico models of unit operations
Towards controlled human Clostridioides difficile colonization and infection
1st Inno4Vac newsletter is out!
The Inno4Vac Scientific and Ethics Advisory Committee has been appointed
A regulatory exchange on diversity and standardisation of 3D mucosal models for vaccine development
Subtopic 1 VAXPRED meeting on 8-9 May 2023
Annual Meeting 2022 Inno4Vac: innovations to accelerate vaccine development and manufacture
First CHIMICHURRI workshop: developing a strategy for new challenge flu and RSV strain selection
Inno4Vac kick-off meeting brings together over 150 partners
EVI to lead Inno4Vac, a new European public-private partnership to innovate vaccine development